Granulocyte infusion: benefit beyond neutrophils?
Newcastle upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK.
T
T
Creasey
Newcastle upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK.
G L
GL
Jones
Newcastle upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK. matthew.collin@ncl.ac.uk.
M
M
Collin
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006098:Granulocytes; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D017708:Leukocyte Transfusion; D008875:Middle Aged; D055732:Pulmonary Aspergillosis / Q000139:chemically induced / Q000628:therapy*
D003561:Cytarabine; D003630:Daunorubicin